<!DOCTYPE html>

<!--[if lt IE 7]>      <html class="no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]-->
<!--[if IE 7]>         <html class="no-js lt-ie9 lt-ie8"> <![endif]-->
<!--[if IE 8]>         <html class="no-js lt-ie9"> <![endif]-->
<!--[if gt IE 8]>      <html class="no-js"> <![endif]-->

<!--[if gt IE 8]><!-->
<html class="no-js" prefix="og: http://ogp.me/ns#">
<!--<![endif]-->

<head>
<title>Distinct expression of C4.4A in colorectal cancer detected by different antibodies Corrigendum in /10.3892/ijo.2016.3694</title>
<meta http-equiv="content-type" content="text/html; charset=UTF-8" />
<meta charset="utf-8" />
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1" />

<meta name="citation_doi" content="10.3892/ijo.2012.1714" />
<meta name="citation_journal_title" content="International Journal of Oncology" />
<meta name="citation_title" content="Distinct expression of C4.4A in colorectal cancer detected by different antibodies Corrigendum in /10.3892/ijo.2016.3694" />

	<meta name="citation_author" content="Yamamoto,Hirofumi " />
	<meta name="citation_author_institution" content="Department of Surgery, Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan" />

	<meta name="citation_author" content="Oshiro,Ryota " />
	<meta name="citation_author_institution" content="Department of Surgery, Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan" />

	<meta name="citation_author" content="Ohtsuka,Masahisa " />
	<meta name="citation_author_institution" content="Department of Surgery, Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan" />

	<meta name="citation_author" content="Uemura,Mamoru " />
	<meta name="citation_author_institution" content="Department of Surgery, Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan" />

	<meta name="citation_author" content="Haraguchi,Naotsugu " />
	<meta name="citation_author_institution" content="Department of Surgery, Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan" />

	<meta name="citation_author" content="Nishimura,Junichi " />
	<meta name="citation_author_institution" content="Department of Surgery, Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan" />

	<meta name="citation_author" content="Takemasa,Ichiro " />
	<meta name="citation_author_institution" content="Department of Surgery, Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan" />

	<meta name="citation_author" content="Mizushima,Tsunekazu " />
	<meta name="citation_author_institution" content="Department of Surgery, Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan" />

	<meta name="citation_author" content="Doki,Yuichiro " />
	<meta name="citation_author_institution" content="Department of Surgery, Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan" />

	<meta name="citation_author" content="Mori,Masaki " />
	<meta name="citation_author_institution" content="Department of Surgery, Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan" />


<meta name="citation_publication_date"
	content="2013-01-01" />
<meta name="citation_volume" content="42" />
<meta name="citation_issue" content="1" />
<meta name="citation_firstpage" content="197" />
<meta name="citation_lastpage" content="201" />
<meta name="citation_publisher" content="Spandidos Publications" />
<meta name="citation_issn" content="1019-6439" />
<meta name="citation_abstract_html_url" content="http://www.spandidos-publications.com/10.3892/ijo.2012.1714/abstract" />
<meta name="citation_pdf_url" content="http://www.spandidos-publications.com/10.3892/ijo.2012.1714/download" />
<meta name="citation_fulltext_world_readable" content="" />

<meta name="keywords"
	content="cancer, oncology, oncogene, molecular medicine, tumor, apoptosis, gene, cell, research, scientific journals, tumour suppressor genes, cell cycle, growth factors" />
<meta name="verify-v1"
	content="qIInQfvSmbVNPO1nn+hEr0GnchYI4j93np2wrWGr29A="></meta>
<meta name="verify-v1"
	content="KOd/fzGN2I+RDbonO/qYB3yaji9QcOddBCxBKx+5j9U="></meta>
	
	
 <meta name="twitter:card" content="summary"></meta>
 <meta name="twitter:title" content="Distinct expression of C4.4A in colorectal cancer detected by different antibodies Corrigendum in /10.3892/ijo.2016.3694"></meta>
 <meta name="twitter:site" content="https://www.spandidos-publications.com/10.3892/ijo.2012.1714"  />
 <meta name="twitter:image" content="https://www.spandidos-publications.com/resources/images/ijo.jpg"/>	
 <meta name="twitter:description" content="The metastasis-associated gene C4.4A encodes a glycolipid-anchored membrane protein expressed in several human malignancies. The present study aimed to perform a detailed assessment of C4.4A expression in colorectal cancer tissues, in terms of intra-cellular localization, intra-tumoral location and difference in molecular weight. To advance this goal, we developed three new antibodies against the C4.4A protein (two polyclonal Abs: C4.4A-119 and C4.4A-277 and one monoclonal Ab: C4.4A GPI-M) to use in addition to the two previously produced polyclonal Abs (C4.4A-81, C4.4A GPI-P). Antibody specificities were confirmed by absorption tests. Western blot analysis and immunohistochemistry showed that the C4.4A-119 and C4.4-277 Abs detected 70-kDa C4.4A, mainly in the cytoplasm, irrespective of intra-tumoral location. The C4.4A GPI-P and C4.4A GPI-M Abs reacted with the membranous ~40-kDa C4.4A, exclusively at the tumor invasive front, and each detected an identical tumor cell population. The tested antibodies showed varied C4.4A detection rates in 33 CRC tissues. The C4.4A-277 Ab yielded the highest positive rate in 29 of 33 CRC tissues (87.9%), while the C4.4A GPI-P and C4.4A GPI-M Abs each only showed 33.3% positivity. The present findings suggest that the GPI anchor signaling sequence may be essential for detecting membranous C4.4A at the invasive front of CRC tissues."/>	
 

 <meta property='og:title' content="Distinct expression of C4.4A in colorectal cancer detected by different antibodies Corrigendum in /10.3892/ijo.2016.3694"/>
 <meta property='og:image:secure_url' content="https://www.spandidos-publications.com/resources/images/ijo.jpg"/>
 <meta name="image" property='og:image' content="https://www.spandidos-publications.com/resources/images/ijo.jpg"/>
 <meta property="og:image:width" content="200" /> 
 <meta property="og:image:height" content="200" />
 <meta property="og:image:type" content="image/jpg" />
 <meta property='og:description' content="The metastasis-associated gene C4.4A encodes a glycolipid-anchored membrane protein expressed in several human malignancies. The present study aimed to perform a detailed assessment of C4.4A expression in colorectal cancer tissues, in terms of intra-cellular localization, intra-tumoral location and difference in molecular weight. To advance this goal, we developed three new antibodies against the C4.4A protein (two polyclonal Abs: C4.4A-119 and C4.4A-277 and one monoclonal Ab: C4.4A GPI-M) to use in addition to the two previously produced polyclonal Abs (C4.4A-81, C4.4A GPI-P). Antibody specificities were confirmed by absorption tests. Western blot analysis and immunohistochemistry showed that the C4.4A-119 and C4.4-277 Abs detected 70-kDa C4.4A, mainly in the cytoplasm, irrespective of intra-tumoral location. The C4.4A GPI-P and C4.4A GPI-M Abs reacted with the membranous ~40-kDa C4.4A, exclusively at the tumor invasive front, and each detected an identical tumor cell population. The tested antibodies showed varied C4.4A detection rates in 33 CRC tissues. The C4.4A-277 Ab yielded the highest positive rate in 29 of 33 CRC tissues (87.9%), while the C4.4A GPI-P and C4.4A GPI-M Abs each only showed 33.3% positivity. The present findings suggest that the GPI anchor signaling sequence may be essential for detecting membranous C4.4A at the invasive front of CRC tissues."/>	
 <meta property='og:url' content="https://www.spandidos-publications.com/10.3892/ijo.2012.1714"/>

<link rel="stylesheet" type="text/css" media="all"
	href="/resources/css/styles.css" />
<link rel="stylesheet" href="/resources/css/jquery.fancybox.css"
	type="text/css" />

<!--[if IE 7]>  <link rel="stylesheet" type="text/css" href="/resources/css/ie7.css"> <![endif]-->
<script src="/resources/js/modernizr-3.3.1.min.js"
	type="text/javascript"></script>

</head>

<body class="ijo">

	<!--[if lt IE 7]>
        <p class="chromeframe">You are using an outdated browser. <a href="http://browsehappy.com/">Upgrade your browser today</a> or <a href="http://www.google.com/chromeframe/?redirect=true">install Google Chrome Frame</a> to better experience this site.</p>
    <![endif]-->

	
	
	<div class="wrapper">

		<div>
		<div class="super wide d-flex pb-4">
			<div class="super fixed_width">
				<ul  >
					<li><a href="/home">Home</a></li>
					
					
					<li><a href="/osats">Submit Manuscript</a></li>
					<!-- <th:block th:if="${session != null and session.user != null and session.user.type == 'user'}"> 
						<li th:if="${session.user.maxYearlyReviews} gt 0" ><a href="/reviews">Reviews</a></li>
					</th:block> -->
					<li><a href="/myaccount">My Account</a></li>
				</ul>			
			</div>
		</div>
	
		<div class="header wide">
			<div class="header fixed_width">
				<div class="header_logo">
					<a href="/home"><img src="/resources/images/spandidoslogo.png"/></a>
				</div>

				<div class="header_search">

					<div id="searchbtn">
						<a href="/advancedsearch/ijo">Advanced Search</a>
						
					</div>
					
					<div  class="searchbox">
							
							<a href="javascript:BasicSearch(&#39;ijo&#39;)"   ><img  src="/resources/images/searchbutton.png"/></a>
							
							<input class="" type="text" id= "searchFor" />		
					</div>
					
					<div> 
						
						
						<ul >
							<li><a href="/register">Register</a></li>
							<li><a href="/login" id="loginLink">Login</a></li>							
						</ul>
						
						
						
					</div>		
					
					
					
				</div>
				<div class="header_nav">
					<ul>
						<li style="width: 8.3%;" class="ol"><a href="/ol">Oncology <br />Letters</a></li>
						<li style="width: 8.3%;" class="ijo"><a href="/ijo">International <br />Journal <br />of Oncology</a></li>
						<li style="width: 8.3%;" class="mco"><a href="/mco">Molecular <br />and Clinical <br />Oncology</a></li>
						<li style="width: 8.3%;" class="etm"><a href="/etm">Experimental <br />and Therapeutic <br />Medicine</a></li>
						<li style="width: 8.3%;" class="ijmm"><a href="/ijmm">International <br />Journal <br />of Molecular <br />Medicine</a></li>
						<li style="width: 8.3%;" class="br"><a href="/br">Biomedical <br />Reports</a></li>
						<li style="width: 8.3%;" class="or"><a href="/or">Oncology <br />Reports</a></li>
						<li style="width: 8.3%;" class="mmr"><a href="/mmr">Molecular <br />Medicine <br />Reports</a></li>						
						<li style="width: 8.3%;" class="wasj"><a  href="/wasj">World Academy <br />of Sciences <br />Journal</a></li>
						<li style="width: 8.3%;" class="ijfn"><a  href="/ijfn">International <br />Journal <br />of Functional<br />Nutrition</a></li>
						<li style="width: 8.3%;" class="ije"><a  href="/ije">International <br />Journal <br />of Epigenetics</a></li>
						<li style="width: 8.3%;" class="mi"><a  href="/mi">Medicine <br />International </a></li>
					</ul>
				</div>                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
			</div>
		</div>
		
		<!-- Journal and Article pages show Journal banner -->
		<div class="banner wide flex">
			<div class="banner fixed_width">
				
				<h1>International<br/>Journal of<br />Oncology</h1>
				
				
				
				
				
				
				
				
				
				
				<img src="/resources/images/bannerijo.jpg" alt="Journal Banner" />
			</div>
		</div>		
	</div>

		<div class="content wide">
			<div class="content fixed_width">
				<div class="content_sidebar">
				<ul class="sidebar_journal_top">
					<li class="sidebar_title"><a href="/ijo">Journal Home</a></li>
					<li >
						<a href="/ijo">Current Issue</a>
					</li>
					<li>
						
						<a href="/ijo/forthcoming">Forthcoming Issue</a>
					</li>
					<li>
						<a id="toggleSpecialIssue" href="#" onclick="$('.toggleSpecialIssue').toggle();return false;">Special Issues</a>
						<ul class="toggleSpecialIssue" style="display:none; margin-bottom: 0px; border:0px ">
							<li><a href="/ijo/specialIssues/open">Open Special Issues</a></li>
							
							<li><a href="/pages/ijo/specialissues">About Special Issues</a></li>
							<li><a href="/osats">Submit Paper</a></li>
						</ul>
					</li>
					
					<li><a href="/ijo/mostread">Most Read</a></li>
					<li>
						<a id="toggleMostCitedDimensions" href="#" onclick="return false">Most Cited (Dimensions)</a>
						<ul class="toggleMostCitedDimensions" style="display:none; margin-bottom: 0px; border:0px ">
							<li><a href="/ijo/mostciteddimensionrecent">Past Two Years</a></li>
							<li><a href="/ijo/mostciteddimension">Total</a></li>
						</ul>
					</li>
					<li><a id="toggleMostCitedCrossRef" href="#" onclick="return false">Most Cited (CrossRef)</a>
						<ul class="toggleMostCitedCrossRef" style="display:none; margin-bottom: 0px; border:0px ">
							<li><a href="/ijo/mostcitedbylastyear">Past Year <span  class="rightsReservedCrossref">0 </span></a></li>
							<li><a href="/ijo/mostcitedby">Total</a></li>
						</ul>
					</li>
					<li><a id="toggleSM" href="#toggleSM" onclick="return false">Social Media</a>
						<ul class="toggleSM" style="display:none; margin-bottom: 0px; border:0px ">
							<li><a class="medium" href="/ijo/1m/mostaltmetricmentions">Past Month</a></li>
							<li><a class="medium" href="/ijo/1y/mostaltmetricmentions">Past Year</a></li>
							<li><a class="medium" href="/ijo/at/mostaltmetricmentions">Total</a></li>
						</ul>
					</li>
					 <li><a href="/ijo/archive">Archive</a></li>
				</ul>
				<ul class="sidebar_journal_bottom">
					<li class="sidebar_title">Information</li>
					<li><a href="/osats">Online Submission</a></li>
					<li><a href="/pages/ijo/info_for_authors">Information for Authors</a></li>
					<li><a href="/languageediting">Language Editing</a></li>
					<li><a href="/pages/info_for_reviewers">Information for Reviewers</a></li>
					<li><a href="/pages/ijo/editorialPol">Editorial Policies</a></li>
					
					<li>
						
						<a href="/pages/ijo/editorial">Editorial Academy</a>
						
					</li>
					<li>
						
						<a href="/pages/join_editorial">Join Editorial Academy</a>
						
					</li>
					
					<li><a href="/pages/ijo/aims_scope">Aims and Scope</a></li>
					<li><a href="/pages/ijo/abstracting" id="abstracting" class="staticContent">Abstracting and Indexing</a></li>
					<li><a href="/pages/ijo/bibliographic">Bibliographic Information</a></li>
					<li><a href="/pages/info_for_librarians">Information for Librarians</a></li>
					<li><a href="/pages/info_for_advertisers">Information for Advertisers</a></li>	
					<li><a href="/pages/reprints">Reprints and permissions</a></li>						
					<li><a href="/pages/ijo/contact">Contact the Editor</a></li>
				</ul>
				
				<ul class="sidebar_journal_bottom">
						<li class="sidebar_title">General Information</li>
						<li><a href="/pages/about">About Spandidos</a></li>
						<li><a href="/pages/conference">Conferences</a></li>
						<li><a href="/pages/jobs">Job Opportunities</a></li>
						<li><a href="/pages/contact">Contact</a></li>
						<li><a href="/pages/terms">Terms and Conditions</a></li>
				 </ul>	
			</div>

				<div class="content_main">
					<div class="content_article">
					
					
						

						

						
							<h1>Distinct expression of C4.4A in colorectal cancer detected by different antibodies </h1>
							
							<h2>
								<span class="red">Corrigendum in:</span> <a href="/10.3892/ijo.2016.3694">/10.3892/ijo.2016.3694</a>
							</h2>
							
							
														
							
						

						

						

						<ul class="article_details">
						
						    
						
							<li><span class="bold">Authors:</span>
								<ul id="authorshipNames">
									
										
											
												<li class="corresponding"
													title="hyamamoto@gesurg.med.osaka-u.ac.jp">Hirofumi  Yamamoto</li>
											
										
										
									
										
										<li>Ryota  Oshiro</li>
									
										
										<li>Masahisa  Ohtsuka</li>
									
										
										<li>Mamoru  Uemura</li>
									
										
										<li>Naotsugu  Haraguchi</li>
									
										
										<li>Junichi  Nishimura</li>
									
										
										<li>Ichiro  Takemasa</li>
									
										
										<li>Tsunekazu  Mizushima</li>
									
										
										<li>Yuichiro  Doki</li>
									
										
										<li>Masaki  Mori</li>
									
								</ul>
							</li>

							<li><p>
									<a class="bold" href="#" id="toggle">View Affiliations</a>
								</p>

								<div class="toggle" style="display: none;">
									<br /> <span class="bold">Affiliations: </span><span>Department of Surgery, Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan</span>
								</div></li>

							<!--<li><span class="bold">Corresponding author:</span> <span th:text="${dispArt.correspondingList}">Author name</span></li>-->
							<li><span class="bold">Published online on:</span> <span
								id="publishedOn">November 22, 2012</span> <span>&nbsp;&nbsp;&nbsp;</span> <span
								id="doi">https://doi.org/10.3892/ijo.2012.1714</span>
							</li>

							<li>
								
									<span  class="bold">Pages: </span>
									<span>197-201</span>
								
								
								
								</li>

							
						</ul>



						<div>

							<div id="metrics">
								<div>
									<span title="The metrics are calculated only from this site"
										class="bold">Metrics: </span> <span class="small"
										title="The metrics are calculated only from this site">Total
										Views: </span> <span
										title="The metrics are calculated only from this site"
										class="bold small" id="postTotalFullArticleViews">0 </span> <span
										class="small">(Spandidos Publications:</span> <span
										class="bold small" id="postFullArticleViews"></span> <span
										class="small"> | PMC Statistics: </span> <span
										class="bold small" id="postPMCFullArticleViews"></span> <span
										class="small">)</span>

									<div>
										<span style="visibility: hidden;"
											title="The metrics are calculated only from this site"
											class="bold">Metrics: </span> <span
											title="The metrics are calculated only from this site"
											class="small">Total PDF Downloads: </span> <span
											title="The metrics are calculated only from this site"
											id="postTotalArticleDownloads" class="bold small">0 </span> <span
											class="small">(Spandidos Publications:</span> <span
											class="bold small" id="postArticleDownloads"></span> <span
											class="small"> | PMC Statistics: </span> <span
											class="bold small" id="postArticlePMCDownloads"></span> <span
											class="small">)</span>
									</div>

								</div>



							</div>
							<div>
								<span id="citationCountId"> <a class="citedByCountId"
									style="margin-left: 0px"
									href="/getTotalCount/10.3892/ijo.2012.1714"></a>
								</span>
								<span id="citation"> <a class="citedBy"
									style="margin-left: 0px"
									href="/citationhtml/10.3892/ijo.2012.1714/html">
										Cited By (CrossRef): </a>
								</span> <span class="bold small" id="citationCount">0</span> <span
									class="bold small"> citations </span>
								<span class="bold small citationAllArticlesClass" id="citationAllArticlesId">
									<a id="citedByIdViewArticles" class="citedBy"
									style="font-size: 15px; text-decoration: none; margin-left: 0px"
									href="/citationhtml/10.3892/ijo.2012.1714/html">
										Loading Articles... </a>
								</span> 
							</div>

							<a class="moreLikeThis" style="display: none"
								href="/morelikethis/23489"></a>

							<div id="citationDiv" style="display: none">
								<h4>This article is mentioned in:</h4>
								<div id="citations"></div>
							</div>

							<span class="__dimensions_badge_embed__"
								data-hide-zero-citations="true" data-legend="always"
								data-style="small_circle" data-doi="10.3892/ijo.2012.1714"></span>
							<script async="async" src="https://badge.dimensions.ai/badge.js"
								charset="utf-8"></script>
							<br></br> <span data-hide-no-mentions="true"
								data-badge-details="right" class='altmetric-embed'
								data-badge-type="donut" data-link-target="_blank" data-doi="10.3892/ijo.2012.1714"></span>
						</div>


						<h4>Abstract</h4>

						


						<div
							id = "articleAbstract">The metastasis-associated gene C4.4A encodes a glycolipid-anchored membrane protein expressed in several human malignancies. The present study aimed to perform a detailed assessment of C4.4A expression in colorectal cancer tissues, in terms of intra-cellular localization, intra-tumoral location and difference in molecular weight. To advance this goal, we developed three new antibodies against the C4.4A protein (two polyclonal Abs: C4.4A-119 and C4.4A-277 and one monoclonal Ab: C4.4A GPI-M) to use in addition to the two previously produced polyclonal Abs (C4.4A-81, C4.4A GPI-P). Antibody specificities were confirmed by absorption tests. Western blot analysis and immunohistochemistry showed that the C4.4A-119 and C4.4-277 Abs detected 70-kDa C4.4A, mainly in the cytoplasm, irrespective of intra-tumoral location. The C4.4A GPI-P and C4.4A GPI-M Abs reacted with the membranous ~40-kDa C4.4A, exclusively at the tumor invasive front, and each detected an identical tumor cell population. The tested antibodies showed varied C4.4A detection rates in 33 CRC tissues. The C4.4A-277 Ab yielded the highest positive rate in 29 of 33 CRC tissues (87.9%), while the C4.4A GPI-P and C4.4A GPI-M Abs each only showed 33.3% positivity. The present findings suggest that the GPI anchor signaling sequence may be essential for detecting membranous C4.4A at the invasive front of CRC tissues.</div>

						<div>
							<div>



<h4>Introduction</h4>
<p>The C4.4A protein was first identified in a highly
metastatic rat pancreatic adenocarcinoma cell line (<a href="#b1-ijo-42-01-0197" class="linksColor">1</a>,<a href="#b2-ijo-42-01-0197" class="linksColor">2</a>). The
human homologue of rat C4.4A is located on chromosome 19q13.1–q13.2
and was cloned in 2001 (<a href="#b3-ijo-42-01-0197" class="linksColor">3</a>).
Studies of the molecular structure indicate that C4.4A is a
glycosylphosphatidyl-inositol (GPI)-anchored membrane protein with
30% homology to the urokinase-type plasminogen activator receptor
(<a href="#b4-ijo-42-01-0197" class="linksColor">4</a>,<a href="#b5-ijo-42-01-0197" class="linksColor">5</a>). In normal human tissues, C4.4A mRNA is
present in placental tissue, skin, esophagus, and leukocytes
(<a href="#b3-ijo-42-01-0197" class="linksColor">3</a>); but the physiological
function of the C4.4A protein is largely unknown. C4.4A expression
is upregulated in some types of human malignancies, and human C4.4A
mRNA has been detected in cancer cell lines, including melanoma,
breast, bladder, and renal cell carcinoma, as well as in tumor
tissue samples from malignant melanoma, colorectal cancer (CRC),
breast cancer, lung carcinoma, and urothelial tumors (<a href="#b5-ijo-42-01-0197" class="linksColor">5</a>–<a href="#b10-ijo-42-01-0197" class="linksColor">10</a>).</p>
<p>We previously detected C4.4A protein expression on
the plasma membranes of tumor cells at the invasive front in 25.6%
of 132 CRCs (<a href="#b11-ijo-42-01-0197" class="linksColor">11</a>). In that study,
we used a polyclonal antibody that recognizes the C4.4A C-terminus
containing the GPI anchor signaling sequence. In contrast, Paret
<span class="italic">et al</span>(<a href="#b9-ijo-42-01-0197" class="linksColor">9</a>) reported that
85.4% of CRC tissues showed distinct C4.4A expression by
immunohistochemistry, and they did not mention an invasive
front-specific expression pattern. We also observed that another
C4.4A polyclonal antibody that was raised against amino acids near
the N-terminus did not react with the C4.4A protein in CRC tissue
samples, while it did recognize C4.4A in the esophageal squamous
epithelium (<a href="#b11-ijo-42-01-0197" class="linksColor">11</a>). These findings
suggest that distinct antibodies detect different species of the
C4.4A protein.</p>
<p>In the present study, we further investigated C4.4A
expression in CRC tissue samples. We developed three novel
antibodies (two polyclonal antibodies: C4.4A-119 and C4.4A-277, and
one monoclonal antibody: C4.4A GPI-M) and tested them in addition
to the two previously produced antibodies (C4.4A-81, and C4.4A
GPI-P) (<a href="#b11-ijo-42-01-0197" class="linksColor">11</a>). Using these
antibodies for immunohistochemistry, we performed a detailed
assessment of the C4.4A protein with regard to expression rates in
CRC cases, intra-cellular localization in tumor cells (cytoplasm or
plasma membrane), and intra-tumoral localization (invasive front,
or intermediate portion to superficial portion of the cancer body).
Western blot analysis was also performed to determine the molecular
weight of the C4.4A protein bound by each antibody. Our results
show that GPI anchor signaling sequence may be essential for
detecting membranous C4.4A at the invasive front of CRC, which is
of clinical significance.</p>


<h4>Materials and methods</h4>

<h5>Tissue samples and cell lines</h5>
<p>All colorectal tissue samples (n=33) were collected
during surgery at the Department of Surgery, Osaka University
(Osaka, Japan). Samples were fixed in buffered formalin at 4°C
overnight, processed through graded ethanol solutions, and embedded
in paraffin. The specimens were appropriately used, with the
approval of the Ethics Committee at the Graduate School of
Medicine, Osaka University. The human colon cancer cell line HCT116
was obtained from the American Type Culture Collection (Manassas,
VA, USA). Cells were grown in DMEM supplemented with 10% fetal
bovine serum (FBS), 100 U/ml penicillin, and 100 <span class="italic">μ</span>g/ml
streptomycin, at 37°C in a humidified incubator, under 5%
CO<span class="subscript">2</span> in air.</p>


<h5>Antibodies</h5>
<p>To generate rabbit polyclonal antibodies, rabbits
were immunized with the target peptides bound to thyroglobulin. The
C4.4A-specific IgG was purified by passage of the antisera over a
peptide column in which the peptide had been coupled to the beads.
To generate the anti-human C4.4A monoclonal antibody, mice (BALB/c
or BDF1, Charles River, Japan) were immunized weekly with
thyroglobulin-conjugated C4.4A peptides (50 <span class="italic">μ</span>g/mouse). We
used partial human C4.4A peptide consisting of amino acid residues
301–316 (AGHQDRSNSGQYPAKG) as an immunogen for the C-terminus
containing a portion of the GPI anchor. The cysteine residue was
combined in the immunogen beforehand for binding to the carrier
protein, bovine thyroglobulin. After four immunizations, the spleen
was isolated and fused with X63Ag8 myeloma cells. Through limited
dilution and the screening process, the 11A1 clone was selected.
The rabbit anti-human actin antibody was purchased from
Sigma-Aldrich (St. Louis, MO, USA).</p>


<h5>Immunohistochemistry</h5>
<p>Tissue sections (4-<span class="italic">μ</span>m thick) were prepared
from paraffin-embedded blocks. After antigen retrieval treatment in
10 mM citrate buffer (pH 6.0) at 95°C for 40 min, immunostaining
was carried out using the Vectastain ABC peroxidase kit (Vector
Laboratories, Burlingame, CA, USA) as we have described previously
(<a href="#b12-ijo-42-01-0197" class="linksColor">12</a>,<a href="#b13-ijo-42-01-0197" class="linksColor">13</a>). The slides were incubated overnight
at 4°C with appropriate antibodies diluted as follows: C4.4A-119,
1:20; C4.4A-278, 1:20; C4.4A GPI-P, 1:200; and C4.4A GPI-M, 1:50.
Non-immunized rabbit IgG or mouse IgG (Vector Laboratories) was
substituted for the primary antibody as a negative control to
exclude possible false-positive responses from the secondary
antibody or from non-specific binding of IgG.</p>


<h5>Western blot analysis</h5>
<p>Western blot analysis was performed as described
previously (<a href="#b14-ijo-42-01-0197" class="linksColor">14</a>,<a href="#b15-ijo-42-01-0197" class="linksColor">15</a>). Briefly, 20-<span class="italic">μ</span>g protein
samples were separated by 12.5% polyacrylamide gel electrophoresis
followed by electroblotting onto a polyvinylidene difluoride
membrane (PVDF). The membrane was incubated for 1 h with the
primary antibodies at the following concentrations: C4.4A-119,
1:50; C4.4A-278, 1:50; C4.4A GPI-P, 1:500; C4.4A GPI-M, 1:50; and
actin, 1:1000. The protein bands were detected using the Amersham
Enhanced Chemiluminescence (ECL) Detection System (Amersham
Biosciences Corp., NJ, USA).</p>


<h5>Absorption test</h5>
<p>For absorption testing, an excess amount of
immunogen peptide was added to the antibody (20 mol:1 mol), the
mixture was incubated overnight at 4°C and was used instead of the
primary antibody.</p>



<h4>Results</h4>

<h5>Generation of C4.4A antibodies</h5>
<p>In this study, we generated two novel rabbit
anti-human C4.4A polyclonal antibodies, C4.4A-119 and C4.4A-277,
and a mouse anti-human C4.4A monoclonal antibody, C4.4A GPI-M. The
immunogens used for C4.4A-119 and C4.4A-277 were
<span class="superscript">119</span><span class="italic">LTSRALDPAGNE SAYPPNGVEC</span> and
<span class="superscript">277</span><span class="italic">SQTP RQGVEHEASR DEEPRLT</span>, respectively
(<a href="#f1-ijo-42-01-0197" class="linksColor">Fig. 1</a>). The anti-human C4.4A
monoclonal antibody C4.4A GPI-M was raised against
<span class="superscript">301</span><span class="italic">AGHQDRSNSGQYPAKG</span> at the C-terminus containing
a portion of the GPI anchor signaling sequence (<a href="#f1-ijo-42-01-0197" class="linksColor">Fig. 1</a>). The
<span class="superscript">301</span><span class="italic">AGHQDRSNSGQYPAKG</span> immunogen was used in our
previous study to generate a GPI-related polyclonal antibody,
anti-human C4.4A antibody-2 antibody, which we also used in the
present study for comparison (designated as C4.4A GPI-P in this
study for simplicity).</p><div id="f1-ijo-42-01-0197"><a class="fancybox" data-fancybox-group="figures" href="/article_images/ijo/42/1/IJO-42-01-0197-g00.jpg" title="Figure 1. - Amino acid sequences of the C4.4A&#xA;protein with the epitopes employed as immunogens in bold. C4.4A-81&#xA;starts at AA 81, C4.4A-119 at AA 119, C4.4A-277 at AA 277, and&#xA;C4.4A GPI-P and C4.4A GPI-M start at AA 301. The boxed area&#xA;indicates the GPI anchor signaling sequence. 309SGQYPAKG&#xA;is destined to be cut off when the C4.4A molecule is anchored onto&#xA;the plasma membrane."><div class="panel"><table><tbody><tr><td width="115px"><img class="panel-image" src="/article_images/ijo/42/1/IJO-42-01-0197-g00.jpg"></img></td><td><h4>Figure 1.</h4><p class="bold">Amino acid sequences of the C4.4A
protein with the epitopes employed as immunogens in bold. C4.4A-81
starts at AA 81, C4.4A-119 at AA 119, C4.4A-277 at AA 277, and
C4.4A GPI-P and C4.4A GPI-M start at AA 301. The boxed area
indicates the GPI anchor signaling sequence. 309SGQYPAKG
is destined to be cut off when the C4.4A molecule is anchored onto
the plasma membrane.</p></td></tr></tbody></table></div></a></div>


<h5>Western blot analysis</h5>
<p>The C4.4A-119 and C4.4A-277 antibodies in HCT116
each produced a band at around 70 kDa, and the absorbed antibodies
eliminated these bands (<a href="#f2-ijo-42-01-0197" class="linksColor">Fig. 2A and
B</a>). On the other hand, the C4.4A GPI-P antibody in HCT116
produced doublet bands at 40 and 52 kDa (<a href="#f2-ijo-42-01-0197" class="linksColor">Fig. 2C</a>), and the absorbed antibody
abolished a band at 40 kDa, which can be visualized on the tissue
sections; similar results were observed with the C4.4A GPI-M
antibody (<a href="#f2-ijo-42-01-0197" class="linksColor">Fig. 2D</a>).</p><div id="f2-ijo-42-01-0197"><a class="fancybox" data-fancybox-group="figures" href="/article_images/ijo/42/1/IJO-42-01-0197-g01.jpg" title="Figure 2. - Western blot analysis for the C4.4A&#xA;protein using lysates from HCT116 colon cancer cells. (A),&#xA;C4.4A-119 antibody; (B), C4.4A-277 antibody; (C), C4.4A GPI-P&#xA;antibody; (D), C4.4A GPI-M antibody. The arrows indicate the band&#xA;corresponding to the C4.4A protein."><div class="panel"><table><tbody><tr><td width="115px"><img class="panel-image" src="/article_images/ijo/42/1/IJO-42-01-0197-g01.jpg"></img></td><td><h4>Figure 2.</h4><p class="bold">Western blot analysis for the C4.4A
protein using lysates from HCT116 colon cancer cells. (A),
C4.4A-119 antibody; (B), C4.4A-277 antibody; (C), C4.4A GPI-P
antibody; (D), C4.4A GPI-M antibody. The arrows indicate the band
corresponding to the C4.4A protein.</p></td></tr></tbody></table></div></a></div>


<h5>Immunohistochemistry</h5>
<p>The C4.4A antibodies yielded positive staining for
the C4.4A protein on tumor cells in CRC tissue specimens, and the
pre-absorbed antibodies abolished this staining (<a href="#f3-ijo-42-01-0197" class="linksColor">Fig. 3</a>).</p><div id="f3-ijo-42-01-0197"><a class="fancybox" data-fancybox-group="figures" href="/article_images/ijo/42/1/IJO-42-01-0197-g02.jpg" title="Figure 3. - Absorption test on CRC tissues. (A),&#xA;C4.4A-119 antibody; (B), C4.4A-277 antibody; (C), C4.4A GPI-P&#xA;antibody; and (D), C4.4A GPI-M antibody. The scale bars indicate&#xA;500 μm (A–D)."><div class="panel"><table><tbody><tr><td width="115px"><img class="panel-image" src="/article_images/ijo/42/1/IJO-42-01-0197-g02.jpg"></img></td><td><h4>Figure 3.</h4><p class="bold">Absorption test on CRC tissues. (A),
C4.4A-119 antibody; (B), C4.4A-277 antibody; (C), C4.4A GPI-P
antibody; and (D), C4.4A GPI-M antibody. The scale bars indicate
500 μm (A–D).</p></td></tr></tbody></table></div></a></div>


<h5>Localization of C4.4A and positive
staining rate in CRC tissues with each antibody</h5>
<p>Immunohistochemistry revealed that the C4.4A protein
was differently detected by each antibody in terms of
intra-cellular and intra-tumoral locations, and positive staining
rate. Using the C4.4A-119 antibody, positive staining was noted in
17 of 33 CRC cases (51.5%); relatively weak cytoplasmic staining
was observed in the tumor cells, irrespective of location in the
tumor body, i.e., superficial to intermediate area or invasive
front (<a href="#f4-ijo-42-01-0197" class="linksColor">Fig. 4A</a>). With the
C4.4A-277 antibody, 29 of 33 CRC samples (87.9%) were positive for
cytoplasmic C4.4A, and staining was observed at both the invasive
front and superficial to intermediate portions (<a href="#f4-ijo-42-01-0197" class="linksColor">Fig. 4A</a>); membranous staining was
generally not evident, but weak positive staining was occasionally
observed in only a portion of the cancer body. On the other hand,
the C4.4A GPI-P antibody produced intense membranous staining at
the invasive front in 11 of 33 CRC cases (33.3%), but this staining
was usually not found at the superficial to intermediate portions
(<a href="#f4-ijo-42-01-0197" class="linksColor">Fig. 4B</a>).</p><div id="f4-ijo-42-01-0197"><a class="fancybox" data-fancybox-group="figures" href="/article_images/ijo/42/1/IJO-42-01-0197-g03.jpg" title="Figure 4. - Immunohistochemistry of C4.4A at&#xA;either a superficial to intermediate portion of the cancer body or&#xA;at the invasive front of CRC tissue. (A), Representative CRC&#xA;samples stained with the C4.4A-119 antibody, the C4.4A-277&#xA;antibody; and (B), the C4.4A GPI-P antibody. The scale bars&#xA;indicate 200 μm (A and B)."><div class="panel"><table><tbody><tr><td width="115px"><img class="panel-image" src="/article_images/ijo/42/1/IJO-42-01-0197-g03.jpg"></img></td><td><h4>Figure 4.</h4><p class="bold">Immunohistochemistry of C4.4A at
either a superficial to intermediate portion of the cancer body or
at the invasive front of CRC tissue. (A), Representative CRC
samples stained with the C4.4A-119 antibody, the C4.4A-277
antibody; and (B), the C4.4A GPI-P antibody. The scale bars
indicate 200 μm (A and B).</p></td></tr></tbody></table></div></a></div>
<p>The C4.4A GPI-M antibody showed a staining pattern
similar to that produced by the C4.4A GPI-P antibody (<a href="#f5-ijo-42-01-0197" class="linksColor">Fig. 5</a>). Staining by both GPI-related
antibodies in serial sections revealed identical heterogeneous
C4.4A expression patterns at the intermediate portion of the cancer
body. The C4.4A GPI-M antibody also provided intense membranous
staining in the tumor cells, only at the invasive front.</p><div id="f5-ijo-42-01-0197"><a class="fancybox" data-fancybox-group="figures" href="/article_images/ijo/42/1/IJO-42-01-0197-g05.jpg" title="Figure 5. - Immunohistochemistry of C4.4A using&#xA;GPI-related antibodies. Serial sections stained with the C4.4A&#xA;GPI-M antibody and the C4.4A GPI-P antibody showed identical&#xA;patterns of C4.4A-positive cells in the cancer glands. Identical&#xA;heterogeneous C4.4A expression patterns were also noted at the&#xA;intermediate portion of the cancer body. The scale bars indicate&#xA;100 μm. A membranous expression pattern was observed at&#xA;tumor invasive fronts with each antibody. The dotted scale bars&#xA;indicate 50 μm."><div class="panel"><table><tbody><tr><td width="115px"><img class="panel-image" src="/article_images/ijo/42/1/IJO-42-01-0197-g05.jpg"></img></td><td><h4>Figure 5.</h4><p class="bold">Immunohistochemistry of C4.4A using
GPI-related antibodies. Serial sections stained with the C4.4A
GPI-M antibody and the C4.4A GPI-P antibody showed identical
patterns of C4.4A-positive cells in the cancer glands. Identical
heterogeneous C4.4A expression patterns were also noted at the
intermediate portion of the cancer body. The scale bars indicate
100 μm. A membranous expression pattern was observed at
tumor invasive fronts with each antibody. The dotted scale bars
indicate 50 μm.</p></td></tr></tbody></table></div></a></div>



<h4>Discussion</h4>
<p>In this study, we used four specific antibodies
against the C4.4A protein, three of which were newly produced.
Antibody specificities were verified by absorption tests, and
efficacies by both western blot analysis and immunohistochemistry.
The use of these distinct antibodies revealed several isoforms of
the C4.4A protein, which differed in terms of molecular weight,
intra-tumoral location, and intra-cellular localization. Western
blot analysis revealed the existence of at least two isoforms: a
long form of ∼70 kDa, and a short form of ∼40 kDa. This finding is
consistent with the report by Paret <span class="italic">et al</span> that the
recombinant C4.4A protein is digested by trypsin treatment from a
long form of over 70 kDa to a proteolytic fragment of 40 kDa
(<a href="#b9-ijo-42-01-0197" class="linksColor">9</a>). Hansen <span class="italic">et al</span> also
observed that both a long form (67 kDa) and short form (40 kDa)
were present in the normal esophageal epithelium and at the
superficial portion of the cancer body of the esophagus, whereas
the short form of ∼40 kDa was predominant in the invasive front of
the cancer body (<a href="#b16-ijo-42-01-0197" class="linksColor">16</a>).</p>
<p>In the present study, we found that the C4.4A-119
and C4.4A-277 antibodies reacted with the long form of C4.4A (70
kDa) and exhibited mainly cytoplasmic intra-cellular localization,
irrespective of intra-tumoral location. In the tested CRC cases,
the C4.4A-119 and C4.4A-277 antibodies showed positive rates of
51.5% and 87.9%, respectively, indicating that cytoplasmic C4.4A
was relatively frequently present in CRC tissues. Paret <span class="italic">et
al</span>(<a href="#b9-ijo-42-01-0197" class="linksColor">9</a>) previously used an
antibody created with immunogens from two different portions of
C4.4A (amino acids 278–302 and 119–138), and showed C4.4A
expression in more than 80% of CRC tissue samples. Another study on
C4.4A expression in esophageal squamous cell carcinoma (ESCC)
showed a 100% detection rate (14 of 14 ESCC cases) using an
antibody that recognizes the Domain III portion of the C4.4A
molecule (<a href="#b5-ijo-42-01-0197" class="linksColor">5</a>,<a href="#b16-ijo-42-01-0197" class="linksColor">16</a>). These findings suggest that C4.4A
could be a sensitive marker for CRC and ESCC when using the
specific antibodies with high C4.4A detection rates.</p>
<p>On the other hand, we found that the C4.4A GPI-P
antibody detected mainly membranous C4.4A at the invasive front of
CRC tissues, at a lower rate of 33.3%. These findings suggest that,
although cytoplasmic C4.4A is commonly detected in CRC tissues,
only certain CRCs expressed membranous C4.4A. We hypothesize that
the membranous type of C4.4A is functionally important and of
clinical significance; it is possible that C4.4A on the plasma
membrane could play a crucial role in invasion and metastasis. We
previously reported that membranous C4.4A was linked to venous
invasion, and associated with poor prognosis (especially
hematogenous metastasis) in CRC (<a href="#b11-ijo-42-01-0197" class="linksColor">11</a>). Moreover, we recently found that
membranous C4.4A was tightly linked to EMT (epithelial-mesenchymal
transition) change, and associated with tumor budding (<a href="#b17-ijo-42-01-0197" class="linksColor">17</a>), a putative hallmark of cell invasion
of CRC (<a href="#b18-ijo-42-01-0197" class="linksColor">18</a>,<a href="#b19-ijo-42-01-0197" class="linksColor">19</a>).</p>
<p>To explore whether the GPI anchor sequence was
essential for detecting membranous C4.4A at the invasive front, we
developed the novel monoclonal antibody C4.4A GPI-M. The antibody
detected a membranous C4.4A expression pattern at the invasive
front, similar to that shown by the C4.4A GPI-P antibody. Both
C4.4A GPI-P and C4.4A GPI-M antibodies produced a band at around 40
kDa. These findings suggest that the C4.4A protein may exist as a
proteolytic fragment on the plasma membrane in a subset of CRC.
Based on these results, we concluded that the GPI anchor signaling
sequence is essential for detecting membranous C4.4A at the
invasive front. The present findings also suggest that C4.4A might
be digested into the short form at the invasive front of CRC when
it links to the plasma membrane via the GPI anchor.</p>
<p>In conclusion, as summarized in <a href="#t1-ijo-42-01-0197" class="linksColor">Table I</a>, we found that the majority of CRC
tissues expressed cytoplasmic C4.4A, and a subset of CRCs displayed
C4.4A on the plasma membrane. Both the C4.4A GPI-M antibody and the
C4.4A GPI-P antibody exhibited membranous expression patterns,
suggesting that the GPI anchor signaling sequence is essential for
detecting membranous C4.4A at the invasive front.</p><div class="panel" id="t1-ijo-42-01-0197"><a href="#tb_t1-ijo-42-01-0197" class="fancybox" data-fancybox-group="tables" title="Table I. - Detection of C4.4A expression by C4.4A&#xA;antibodies."><table><tbody><tr><td width="115px"><img class="panel-image" src="/images/table-icon.jpg"></img></td><td><h4>Table I.</h4><p><b>Detection of C4.4A expression by C4.4A
antibodies.</b></p></td></tr></tbody></table></a><div style="display:none;"><div id="tb_t1-ijo-42-01-0197"><h4>Table I.</h4><p><b>Detection of C4.4A expression by C4.4A
antibodies.</b></p><table xmlns="http://www.w3.org/1999/xhtml" frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1"><a name="d7e678" id="d7e678" shape="rect"><!-- named anchor --></a></th><th align="center" valign="middle" rowspan="1" colspan="1"><a name="d7e679" id="d7e679" shape="rect"><!-- named anchor --></a>C4.4A-119</th><th align="center" valign="middle" rowspan="1" colspan="1"><a name="d7e681" id="d7e681" shape="rect"><!-- named anchor --></a>C4.4A-277</th><th align="center" valign="middle" rowspan="1" colspan="1"><a name="d7e683" id="d7e683" shape="rect"><!-- named anchor --></a>C4.4 GPI-P</th><th align="center" valign="middle" rowspan="1" colspan="1"><a name="d7e685" id="d7e685" shape="rect"><!-- named anchor --></a>C4.4 GPI-M</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><a name="d7e689" id="d7e689" shape="rect"><!-- named anchor --></a>Positive rate in CRC
tissue</td><td align="center" valign="top" rowspan="1" colspan="1"><a name="d7e691" id="d7e691" shape="rect"><!-- named anchor --></a>51.5%</td><td align="center" valign="top" rowspan="1" colspan="1"><a name="d7e693" id="d7e693" shape="rect"><!-- named anchor --></a>87.9%</td><td align="center" valign="top" rowspan="1" colspan="1"><a name="d7e695" id="d7e695" shape="rect"><!-- named anchor --></a>33.3%</td><td align="center" valign="top" rowspan="1" colspan="1"><a name="d7e697" id="d7e697" shape="rect"><!-- named anchor --></a>33.3%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><a name="d7e700" id="d7e700" shape="rect"><!-- named anchor --></a>Intra-cellular
localization</td><td align="center" valign="top" rowspan="1" colspan="1"><a name="d7e702" id="d7e702" shape="rect"><!-- named anchor --></a>Cytoplasm</td><td align="center" valign="top" rowspan="1" colspan="1"><a name="d7e704" id="d7e704" shape="rect"><!-- named anchor --></a>Cytoplasm
(occasionally plasma membrane)</td><td align="center" valign="top" rowspan="1" colspan="1"><a name="d7e706" id="d7e706" shape="rect"><!-- named anchor --></a>Plasma membrane</td><td align="center" valign="top" rowspan="1" colspan="1"><a name="d7e708" id="d7e708" shape="rect"><!-- named anchor --></a>Plasma membrane</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><a name="d7e711" id="d7e711" shape="rect"><!-- named anchor --></a>Intra-tumor
localization</td><td align="center" valign="top" rowspan="1" colspan="1"><a name="d7e713" id="d7e713" shape="rect"><!-- named anchor --></a>All layers</td><td align="center" valign="top" rowspan="1" colspan="1"><a name="d7e715" id="d7e715" shape="rect"><!-- named anchor --></a>All layers</td><td align="center" valign="top" rowspan="1" colspan="1"><a name="d7e717" id="d7e717" shape="rect"><!-- named anchor --></a>Limited to invasive
front</td><td align="center" valign="top" rowspan="1" colspan="1"><a name="d7e719" id="d7e719" shape="rect"><!-- named anchor --></a>Limited to invasive
front</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><a name="d7e722" id="d7e722" shape="rect"><!-- named anchor --></a>Molecular weight</td><td align="center" valign="top" rowspan="1" colspan="1"><a name="d7e724" id="d7e724" shape="rect"><!-- named anchor --></a>70 kDa</td><td align="center" valign="top" rowspan="1" colspan="1"><a name="d7e726" id="d7e726" shape="rect"><!-- named anchor --></a>70 kDa</td><td align="center" valign="top" rowspan="1" colspan="1"><a name="d7e728" id="d7e728" shape="rect"><!-- named anchor --></a>40 kDa</td><td align="center" valign="top" rowspan="1" colspan="1"><a name="d7e730" id="d7e730" shape="rect"><!-- named anchor --></a>40 kDa</td></tr></tbody></table></div></div></div>



<a class="linksColor">
</a>

<a class="linksColor">
</a>
<h4>Abbreviations:</h4><table xmlns="http://www.w3.org/1999/xhtml" class="def-list"><tr id="d7e393"><td class="def-term" id="d7e394" rowspan="1" colspan="1">
<p>Ab</p>
</td><td valign="def-def" id="d7e396" rowspan="1" colspan="1">
<p class="first" id="d7e397">antibody</p>
</td></tr><tr id="d7e399"><td class="def-term" id="d7e400" rowspan="1" colspan="1">
<p>CRC</p>
</td><td valign="def-def" id="d7e402" rowspan="1" colspan="1">
<p class="first" id="d7e403">colorectal cancer</p>
</td></tr><tr id="d7e405"><td class="def-term" id="d7e406" rowspan="1" colspan="1">
<p>GPI</p>
</td><td valign="def-def" id="d7e408" rowspan="1" colspan="1">
<p class="first" id="d7e409">glycosylphosphatidyl-inositol</p>
</td></tr></table>


<a class="linksColor">
</a>
<h4>Acknowledgements</h4>
<p>This work was supported by a
Grant-in-Aid for Cancer Research from the Ministry of Education,
Science, Sports, and Culture Technology, Japan, to H.Y.</p>

<a class="linksColor">
</a>
<a class="linksColor">
</a>
<h4>References</h4>
<table xmlns="http://www.w3.org/1999/xhtml" class="ref-list"><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">1.</span> <a name="b1-ijo-42-01-0197" id="b1-ijo-42-01-0197" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e420" id="d7e420" shape="rect">
<!-- named anchor --></a>Claas C, Herrmann K, Matzku S, Möller P
and Zöller M: Developmentally regulated expression of
metastasis-associated antigens in the rat. Cell Growth Differ.
7:663–678. 1996.<a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/8732676" id="d7e422" name="d7e422" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">2.</span> <a name="b2-ijo-42-01-0197" id="b2-ijo-42-01-0197" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e427" id="d7e427" shape="rect">
<!-- named anchor --></a>Matzku S, Wenzel A, Liu S and Zöller M:
Antigenic differences between metastatic and nonmetastatic BSp73
rat tumor variants characterized by monoclonal antibodies. Cancer
Res. 49:1294–1299. 1989.<a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/2917359" id="d7e429" name="d7e429" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">3.</span> <a name="b3-ijo-42-01-0197" id="b3-ijo-42-01-0197" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e434" id="d7e434" shape="rect">
<!-- named anchor --></a>Würfel J, Seiter S, Stassar M, et al:
Cloning of the human homologue of the metastasis-associated rat
C4.4A. Gene. 262:35–41. 2001.<a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/11179665" id="d7e436" name="d7e436" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">4.</span> <a name="b4-ijo-42-01-0197" id="b4-ijo-42-01-0197" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e441" id="d7e441" shape="rect">
<!-- named anchor --></a>Rösel M, Claas C, Seiter S, Herlevsen M
and Zöller M: Cloning and functional characterization of a new
phosphatidyl-inositol anchored molecule of a metastasizing rat
pancreatic tumor. Oncogene. 17:1989–2002. 1998.<a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/9788443" id="d7e443" name="d7e443" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">5.</span> <a name="b5-ijo-42-01-0197" id="b5-ijo-42-01-0197" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e448" id="d7e448" shape="rect">
<!-- named anchor --></a>Hansen LV, Gårdsvoll H, Nielsen BS, et al:
Structural analysis and tissue localization of human C4.4A: a
protein homologue of the urokinase receptor. Biochem J.
380:845–857. 2004. <a target="xrefwindow" href="http://dx.doi.org/10.1042/BJ20031478" id="d7e450" name="d7e450" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Structural%20analysis%20and%20tissue%20localization%20of%20human%20C4.4A:%20a%20protein%20homologue%20of%20the%20urokinase%20receptor" id="d7e453" name="d7e453" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/15012588" id="d7e456" name="d7e456" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">6.</span> <a name="b6-ijo-42-01-0197" id="b6-ijo-42-01-0197" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e461" id="d7e461" shape="rect">
<!-- named anchor --></a>Hansen LV, Skov BG, Ploug M and Pappot H:
Tumour cell expression of C4.4A, a structural homologue of the
urokinase receptor, correlates with poor prognosis in non-small
cell lung cancer. Lung Cancer. 58:260–266. 2007. <a target="xrefwindow" href="http://dx.doi.org/10.1016/j.lungcan.2007.06.025" id="d7e463" name="d7e463" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Tumour%20cell%20expression%20of%20C4.4A,%20a%20structural%20homologue%20of%20the%20urokinase%20receptor,%20correlates%20with%20poor%20prognosis%20in%20non-small%20cell%20lung%20cancer" id="d7e466" name="d7e466" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/17706320" id="d7e469" name="d7e469" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">7.</span> <a name="b7-ijo-42-01-0197" id="b7-ijo-42-01-0197" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e474" id="d7e474" shape="rect">
<!-- named anchor --></a>Seiter S, Stassar M, Rappl G, Reinhold U,
Tilgen W and Zöller M: Upregulation of C4.4A expression during
progression of melanoma. J Invest Dermatol. 116:344–347. 2001.
<a target="xrefwindow" href="http://dx.doi.org/10.1046/j.1523-1747.2001.01230.x" id="d7e476" name="d7e476" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Upregulation%20of%20C4.4A%20expression%20during%20progression%20of%20melanoma" id="d7e479" name="d7e479" shape="rect">Google Scholar</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">8.</span> <a name="b8-ijo-42-01-0197" id="b8-ijo-42-01-0197" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e484" id="d7e484" shape="rect">
<!-- named anchor --></a>Fletcher G, Patel S, Tyson K, et al: hAG-2
and hAG-3, human homologues of genes involved in differentiation,
are associated with oestrogen receptor-positive breast tumours and
interact with metastasis gene C4.4a and dystroglycan. Br J Cancer.
88:579–585. 2003. <a target="xrefwindow" href="http://dx.doi.org/10.1038/sj.bjc.6600740" id="d7e486" name="d7e486" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=hAG-2%20and%20hAG-3,%20human%20homologues%20of%20genes%20involved%20in%20differentiation,%20are%20associated%20with%20oestrogen%20receptor-positive%20breast%20tumours%20and%20interact%20with%20metastasis%20gene%20C4.4a%20and%20dystroglycan" id="d7e489" name="d7e489" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/12592373" id="d7e492" name="d7e492" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">9.</span> <a name="b9-ijo-42-01-0197" id="b9-ijo-42-01-0197" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e497" id="d7e497" shape="rect">
<!-- named anchor --></a>Paret C, Hildebrand D, Weitz J, et al:
C4.4A as a candidate marker in the diagnosis of colorectal cancer.
Br J Cancer. 97:1146–1156. 2007. <a target="xrefwindow" href="http://dx.doi.org/10.1038/sj.bjc.6604012" id="d7e499" name="d7e499" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=C4.4A%20as%20a%20candidate%20marker%20in%20the%20diagnosis%20of%20colorectal%20cancer" id="d7e502" name="d7e502" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/17912244" id="d7e505" name="d7e505" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">10.</span> <a name="b10-ijo-42-01-0197" id="b10-ijo-42-01-0197" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e510" id="d7e510" shape="rect">
<!-- named anchor --></a>Smith BA, Kennedy WJ, Harnden P, Selby PJ,
Trejdosiewicz LK and Southgate J: Identification of genes involved
in human urothelial cell - matrix interactions: implications for
the progression pathways of malignant urothelium. Cancer Res.
61:1678–1685. 2001.<a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/11245483" id="d7e512" name="d7e512" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">11.</span> <a name="b11-ijo-42-01-0197" id="b11-ijo-42-01-0197" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e518" id="d7e518" shape="rect">
<!-- named anchor --></a>Konishi K, Yamamoto H, Mimori K, et al:
Expression of C4.4A at the invasive front is a novel prognostic
marker for disease recurrence of colorectal cancer. Cancer Sci.
101:2269–2277. 2010. <a target="xrefwindow" href="http://dx.doi.org/10.1111/j.1349-7006.2010.01674.x" id="d7e520" name="d7e520" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Expression%20of%20C4.4A%20at%20the%20invasive%20front%20is%20a%20novel%20prognostic%20marker%20for%20disease%20recurrence%20of%20colorectal%20cancer" id="d7e523" name="d7e523" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/20825414" id="d7e526" name="d7e526" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">12.</span> <a name="b12-ijo-42-01-0197" id="b12-ijo-42-01-0197" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e531" id="d7e531" shape="rect">
<!-- named anchor --></a>Noura S, Yamamoto H, Ohnishi T, et al:
Comparative detection of lymph node micrometastases of stage II
colorectal cancer by reverse transcriptase polymerase chain
reaction and immunohistochemistry. J Clin Oncol. 20:4232–4241.
2002. <a target="xrefwindow" href="http://dx.doi.org/10.1200/JCO.2002.10.023" id="d7e533" name="d7e533" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Comparative%20detection%20of%20lymph%20node%20micrometastases%20of%20stage%20II%20colorectal%20cancer%20by%20reverse%20transcriptase%20polymerase%20chain%20reaction%20and%20immunohistochemistry" id="d7e536" name="d7e536" shape="rect">Google Scholar</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">13.</span> <a name="b13-ijo-42-01-0197" id="b13-ijo-42-01-0197" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e541" id="d7e541" shape="rect">
<!-- named anchor --></a>Yamamoto H, Kondo M, Nakamori S, et al:
JTE-522, a cyclooxygenase-2 inhibitor, is an effective
chemopreventive agent against rat experimental liver fibrosis.
Gastroenterology. 125:556–571. 2003.<a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/12891558" id="d7e543" name="d7e543" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">14.</span> <a name="b14-ijo-42-01-0197" id="b14-ijo-42-01-0197" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e548" id="d7e548" shape="rect">
<!-- named anchor --></a>Takemasa I, Yamamoto H, Sekimoto M, et al:
Overexpression of CDC25B phosphatase as a novel marker of poor
prognosis of human colorectal carcinoma. Cancer Res. 60:3043–3050.
2000.<a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/10850455" id="d7e550" name="d7e550" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">15.</span> <a name="b15-ijo-42-01-0197" id="b15-ijo-42-01-0197" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e555" id="d7e555" shape="rect">
<!-- named anchor --></a>Yamamoto H, Soh JW, Shirin H, et al:
Comparative effects of overexpression of p27<sup>Kip1</sup> and
p21<sup>Cip1/Waf1</sup> on growth and differentiation in human
colon carcinoma cells. Oncogene. 18:103–115. 1999.</p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">16.</span> <a name="b16-ijo-42-01-0197" id="b16-ijo-42-01-0197" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e566" id="d7e566" shape="rect">
<!-- named anchor --></a>Hansen LV, Laerum OD, Illemann M, Nielsen
BS and Ploug M: Altered expression of the urokinase receptor
homologue, C4.4A, in invasive areas of human esophageal squamous
cell carcinoma. Int J Cancer. 122:734–741. 2008. <a target="xrefwindow" href="http://dx.doi.org/10.1002/ijc.23082" id="d7e568" name="d7e568" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Altered%20expression%20of%20the%20urokinase%20receptor%20homologue,%20C4.4A,%20in%20invasive%20areas%20of%20human%20esophageal%20squamous%20cell%20carcinoma" id="d7e571" name="d7e571" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/17849475" id="d7e574" name="d7e574" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">17.</span> <a name="b17-ijo-42-01-0197" id="b17-ijo-42-01-0197" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e579" id="d7e579" shape="rect">
<!-- named anchor --></a>Oshiro R, Yamamoto H, Takahashi H, et al:
C4.4A is associated with tumor budding and epithelial-mesenchymal
transition of colorectal cancer. Cancer Sci. 103:1155–1164. 2012.
<a target="xrefwindow" href="http://dx.doi.org/10.1111/j.1349-7006.2012.02263.x" id="d7e581" name="d7e581" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=C4.4A%20is%20associated%20with%20tumor%20budding%20and%20epithelial-mesenchymal%20transition%20of%20colorectal%20cancer" id="d7e584" name="d7e584" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/22404718" id="d7e587" name="d7e587" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">18.</span> <a name="b18-ijo-42-01-0197" id="b18-ijo-42-01-0197" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e592" id="d7e592" shape="rect">
<!-- named anchor --></a>Hase K, Shatney C, Johnson D, Trollope M
and Vierra M: Prognostic value of tumor budding in patients with
colorectal cancer. Dis Colon Rectum. 36:627–635. 1993. <a target="xrefwindow" href="http://dx.doi.org/10.1007/BF02238588" id="d7e594" name="d7e594" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Prognostic%20value%20of%20tumor%20budding%20in%20patients%20with%20colorectal%20cancer" id="d7e597" name="d7e597" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/8348847" id="d7e600" name="d7e600" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">19.</span> <a name="b19-ijo-42-01-0197" id="b19-ijo-42-01-0197" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e605" id="d7e605" shape="rect">
<!-- named anchor --></a>Ueno H, Murphy J, Jass J, Mochizuki H and
Talbot I: Tumour-budding as an index to estimate the potential of
aggressiveness in rectal cancer. Histopathology. 40:127–132. 2002.
<a target="xrefwindow" href="http://dx.doi.org/10.1046/j.1365-2559.2002.01324.x" id="d7e607" name="d7e607" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Tumour-budding%20as%20an%20index%20to%20estimate%20the%20potential%20of%20aggressiveness%20in%20rectal%20cancer" id="d7e610" name="d7e610" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/11952856" id="d7e613" name="d7e613" shape="rect">PubMed/NCBI</a></p>
</td></tr></table>





</div>
						</div>

						<div>
						   
						</div>

						<div>
							
						</div>

						<div id="moreLikeThisDiv">
	
	<h4>Related Articles</h4>
	<ul style="list-style-type:disc" id="moreLikeThisUl" class="moreLikeThisClassFragment">
        
     </ul>
	          		
		
	</div>

						<div class="article_interactive">
							<ul class="article_icons">
								<li><a href="/10.3892/ijo.2012.1714/abstract"><img
										src="/resources/images/iconabstract.png" alt="Abstract" /></a></li>

								<li><a href="/10.3892/ijo.2012.1714?text=fulltext">
										<img src="/resources/images/iconarticle.png"
										title="View Full Article" />
								</a> </li>

								<li><a href="/10.3892/ijo.2012.1714/download"> <img
										src="/resources/images/icondownload.png"
										title="Download Article" />
								</a> </li>

							</ul>

							<!-- AddThis Button -->
							<ul
								class="article_sharing addthis_toolbox addthis_default_style addthis_32x32_style">

								

								

								

								<li><a
									class="at300b"
									href="https://twitter.com/intent/follow?screen_name=@IjOncology">
										<img src="/resources/images/twitter_32.png"
										alt="Twitter" />
								</a></li>

								

								

								

								
								<li><a class="addthis_button_facebook"></a></li>
								<li><a class="addthis_button_preferred_3"></a></li>
								<li><a class="addthis_button_preferred_4"></a></li>
								<li><a class="addthis_button_compact"></a></li>
							</ul>
						</div>
					</div>
				</div>

				<div class="journal_information">
					<!-- Duplicated from Journal to avoid caching issue if a fragment -->
					<div class="journal_details">
						<div>
							<img src="/ISSUE_IMAGES/ijo_42_1.jpg"
								alt="Journal Cover" />
						</div>
						
											
						
						<p class="bold">
							<span class="bold">January 2013</span> 
							<br/>
							<span>Volume 42 Issue 1</span>
						</p>
						<p>
							Print ISSN: <span>1019-6439</span><br />
							Online ISSN:<span>1791-2423</span><br />
						</p>

						<p>
							<a href="/myaccount/updateaccountdetails?etocUpdate=1">Sign
								up for eToc alerts</a>
						</p>

						<p>
							<a href="/var/library_recommendation_form.pdf">Recommend to
								Library</a>
						</p>
					</div>

					<div class="article_sidebar">
						<ul>
							<li class="sidebar_title">Article Options</li>
							<li class="sidebar_subtitle">Viewing Options</li>
							<li><a href="/10.3892/ijo.2012.1714/abstract">View
									Abstract</a></li>
							<li><a id="isFullTextVisible" href="/10.3892/ijo.2012.1714?text=fulltext">Full
									Text</a></li>
							<li><a id="downloadPDFURL" href="/10.3892/ijo.2012.1714/download">
									Download PDF </a> </li>


							<li>
								</li>

							<li class="sidebar_subtitle">Citations</li>
							<li><a href='#' class='osx'>Cite This Article</a></li>
							<li><a href="/downloadRisFile/10.3892/ijo.2012.1714">Download Citation</a></li>



							<li id="track_citation"><a href="/trackCitation/10.3892/ijo.2012.1714"
								title="If you would like to be notified via email each time this article is cited, please click on the link.">Create
									Citation Alert</a></li>
							<li id="remove_track_citation"><a href="/removeTrackCitation/10.3892/ijo.2012.1714"
								title="If you would like not to be notified via email each time this article is cited, please click on the link.">Remove
									Citation Alert</a></li>
							<li><a href="http://scholar.google.co.uk/scholar?hl=en&amp;q=related:http://www.spandidos-publications.com/10.3892/ijo.2012.1714">Cited
									By</a></li>
							<li class="sidebar_subtitle">Related Articles</li>
							<li><a href="#moreLikeThisDiv">on Spandidos Publications</a></li>
							<li class="sidebar_subtitle">Similar Articles</li>
							<li><a href="http://scholar.google.co.uk/scholar?hl=en&amp;q=related:http://www.spandidos-publications.com/10.3892/ijo.2012.1714">on
									Google Scholar</a></li>
							<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?cmd=Link&amp;db=pubmed&amp;dbFrom=PubMed&amp;from_uid=23489&amp;holding=f1000,f1000m,isrctn">on
									Pub Med</a></li>
							<li class="sidebar_subtitle">Copyright</li>
							<li><a href="http://www.copyright.com/openurl.do?issn=1791-2423">&copy;
									Get Permissions</a></li>
						</ul>

						<ul class="fixed_width_scopus">

							<li class="sidebar_title"><a href="/ijo">Journal Metrics</a></li>
							<li>Impact
								Factor: <span class="impact_factor_font">5.65</span>
							</li>

							<li>Ranked
								<span class="impact_factor_font"></span>

								<span>Oncology</span> <br /> (total
								number of cites)
							</li>

							<li>
								CiteScore: <span class="impact_factor_font">8.2</span> 
							</li>

							<li>CiteScore
								Rank: <span class="impact_factor_font">Q1: #52/340</span> <span>Oncology</span> 
							</li>

							<li>
								Source Normalized Impact per Paper (SNIP): <span
								class="impact_factor_font">1.045</span>
								
							</li>
							<li>
								SCImago Journal Rank (SJR): <span class="impact_factor_font">1.405</span> 
							</li>
						</ul>
					</div>






					<div class="article_sidebar twitter-articles">
						<div>
							<a class="twitter-timeline" data-width="25" data-tweet-limit="5"
								href="https://twitter.com/IjOncology?ref_src=twsrc%5Etfw">Tweets
								by @IjOncology</a>
						</div>
						<div class="article-twitter-buttons">
							<a href="https://twitter.com/IjOncology?ref_src=twsrc%5Etfw"
								class="twitter-follow-button" data-show-screen-name="false"
								data-dnt="true" data-show-count="false">Follow @IjOncology</a>

						</div>
					</div>


					

					


					


					

					

					


					

				</div>


			</div>

		</div>





		<div class="wide">
	
	<div class="event fixed_width">
			<a id="downloadCancerStoryPdf"  class="staticContent" href="#">
					<img src="/resources/images/cancer_story_banner.jpg" alt="The Cancer Story" />
			</a>
				
				
		</div>
	
		<div class="event fixed_width">
				<a href="http://www.worldacademyofsciences.com/rome2020.html" class="staticContent">
				<img src="/resources/images/1st_conference.jpg" alt="International Symposium on Molecular Medicine Conference Banner" />
				</a>				
		</div>
		
				
		<div class="event fixed_width">
				<a href="/pages/conference" class="staticContent">
				<img src="/resources/images/conferencebanner.jpg" alt="World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner" />
				</a>					
		</div>
		
		<div class="event fixed_width">
				<a href="http://www.worldacademyofsciences.com/china2020.html" class="staticContent">
				<img src="/resources/images/3rd_conference.jpg" alt="28th International Symposium on Molecular Medicine" />
				</a>				
		</div>
		
		<div class="event fixed_width">
				<a href="http://www.worldacademyofsciences.com/chile2020.html" class="staticContent">
				<img src="/resources/images/2nd_conference.jpg" alt="International Symposium on Molecular Medicine Conference Banner" />
				</a>				
		</div>	
		
		
		<div class="event fixed_width">
				<a href="http://www.worldacademyofsciences.com" class="staticContent">
				<img src="/resources/images/world_of_academy_banner.jpg" alt="World Academy Of Sciences Banner" />
				</a>				
		</div>
	
			
			
		
		
	</div>
		<div class="footer wide">
	    
		 <div id="navbar" align="center" class="fixed_width footer">
			 			 
		 <div class="gdpr_table" >
			<div class="gdpr_row">
				<div class="gdpr_cell_header">
					<p><strong>This site uses cookies</strong></p>
				</div>		
					
			</div>
			<div class="gdpr_row">
				<div class="gdpr_cell_text">
					<p>You can change your cookie settings at any time by following the instructions in our <a	href="https://www.spandidos-publications.com/pages/cookies"	target="_blank">Cookie Policy</a>. To find out more, you may read our
					<a	href="https://www.spandidos-publications.com/pages/privacy"	target="_blank">Privacy Policy</a>. 
					<a href="#"  id="gdprButton"	class="gdpr_button">I agree</a>	
					</p>
				</div>			
						
			</div>
		</div>
			  
		</div>


		<div class="footer fixed_width">
				<div class="footer_copyright">
						<p  id="rightsReserved">0 </p>
			</div>
			
			
			<div class="footer_links">
				<ul class="social">
					<li>
						<a href="https://twitter.com/intent/follow?screen_name=@SpandidosP">  <img src="/resources/images/twitter.png" alt="Twitter"/> </a>             
					</li>
					<li>
						<a href="http://www.linkedin.com/company/2926613" title="Follow us on LinkedIn"><img src="/resources/images/linkedin.png" alt="LinkedIn"/></a>
					</li>
					<li>
						<a href="https://www.facebook.com/SpandidosPublications" title="Likes us on Facebook"><img src="/resources/images/facebook.png" alt="Facebook"/></a>
					</li>
					
				</ul>
				<ul class="footer_nav">
					<li><a href="/pages/about" id="about" class="staticContent">About</a></li>
					<li>
						<a href="/pages/contact" id="Contact" class="staticContent">Contact</a>
					</li>
					<li><a href="/pages/help">Help</a></li>
					<li><a href="/pages/cookies">Cookie Policy</a></li>
					<li><a href="/pages/privacy">Privacy Policy</a></li>

				</ul>
			</div>
		</div>
		
		 
		<div id="growl" class="bottom-left"></div>
		
	<!--Add the following script at the bottom of the web page (before </body></html>)-->
<script type="text/javascript">function add_chatwidget(){var hccid=66058258;var nt=document.createElement("script");nt.async=true;nt.src="https://www.mylivechat.com/chatwidget.aspx?hccid="+hccid;var ct=document.getElementsByTagName("script")[0];ct.parentNode.insertBefore(nt,ct);}
add_chatwidget();</script>
		
		<script src="/resources/js/jquery-3.4.1.min.js" type="text/javascript"></script>
		<script src="/resources/js/jquery-migrate-3.1.0.min.js" type="text/javascript"></script>

		<script src="/resources/js/app.js" type="text/javascript"></script>
		<script src="/resources/js/js.cookie-2.2.0.min.js"></script>
		
		 <script>
  		  	/*<![CDATA[*/
  		  	  $(document).ready(function () {
  		  		  		  		
  		  		if(null){  		  			
  		  		
  		  			sessionStorage.setItem("orcid_logout_uri", null);
  		  		}
  	
  		  		$("#rightsReserved").html('Copyright &copy; Spandidos Publications ' +(new Date()).getFullYear()+'. All rights reserved.');
  		  	});
  		  		
			 /*]]>*/
   		 </script>
		
		<script type="text/javascript">
			(function(b, o, i, l, e, r) {
				b.GoogleAnalyticsObject = l;
				b[l] || (b[l] =
						function() {
							(b[l].q = b[l].q || []).push(arguments)
						});
				b[l].l = +new Date;
				e = o.createElement(i);
				r = o.getElementsByTagName(i)[0];
				e.src = '//www.google-analytics.com/analytics.js';
				r.parentNode.insertBefore(e, r)
			}(window, document, 'script', 'ga'));
			ga('create', 'UA-45385578-1');
			ga('send', 'pageview');
		</script>
			<script async="async" crossorigin="anonymous" src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
		<!-- Google Code for English -->
		<!-- Remarketing tags may not be associated with personally identifiable information or placed on pages related to sensitive categories. For instructions on adding this tag and more information on the above requirements, read the setup guide: google.com/ads/remarketingsetup -->
		<script type="text/javascript">
			/* <![CDATA[ */
			var google_conversion_id = 982681053;
			var google_conversion_label = "ewoHCKvwggoQ3YvK1AM";
			var google_custom_params = window.google_tag_params;
			var google_remarketing_only = true;
			/* ]]> */
		</script>
		<script type="text/javascript" src="//www.googleadservices.com/pagead/conversion.js">
		</script>
		
		<noscript>
			<div style="display:inline;">
				<img height="1" width="1" style="border-style:none;" alt="" src="//googleads.g.doubleclick.net/pagead/viewthroughconversion/982681053/?value=1.00&amp;label=ewoHCKvwggoQ3YvK1AM&amp;guid=ON&amp;script=0"/>
			</div>
		</noscript>
	<script>
    /*<![CDATA[*/
    	
    	$( "#gdprButton" ).click(function() {
    		Cookies.set('spandidos-gdpr', 'true', { expires: 365 });
   		 	$('#navbar').hide();
   		   $(window).scroll(function() {      		
         	 $('#navbar').hide();      		  
         	});
		});
		
		$('#logout').click(function() { 					
					
			forceSignOut();					
		});
    	
    	function forceSignOut(){
    		
    		let ocridlogouturl = sessionStorage.getItem("orcid_logout_uri");    		
    		ocridlogouturl = removeDoubleQuote(ocridlogouturl);    		
    		
    		$.ajax({
                url: ocridlogouturl,
                dataType: 'jsonp',
                success: function(result,status,xhr) {
                    console.log("Logged In: " + result.loggedIn);
                },
                error: function (xhr, status, error) {
                	console.log(status);
                }
            });
    	}
    	
    	function removeDoubleQuote(url){
    		return url.replace(/['"]+/g, '');
    	}
    
    	//Show guest editors list only if it has a person
        $(document).ready(function () {	
        	
	  		$( ".guestEditors" ).each(function() {
	  			
	  			if($(this).children().length > 0) {
		  			$(this).parent().show();
		  		}
	  		 
	  		});
	  	});
	/*]]>*/
	 </script>
		
	</div>

		<script type='text/javascript'
			src="/resources/js/jquery.simplemodal.js"></script>
		<script type='text/javascript' src="/resources/js/osx.js"></script>
		<!-- modal content -->
		<div id="osx-modal-content">
			<div id="osx-modal-title">Copy and paste a formatted citation</div>
			<div class="close">
				<a href="#" class="simplemodal-close">x</a>
			</div>
			<div id="osx-modal-data">
				<div class="inline">
					<div>
						<div class="citationFormat">Spandidos Publications style</div>
						<div class="citation">Yamamoto H, Oshiro R, Ohtsuka M, Uemura M, Haraguchi N, Nishimura J, Takemasa I, Mizushima T, Doki Y, Mori M, Mori M, et al: Distinct expression of C4.4A in colorectal cancer detected by different antibodies Corrigendum in /10.3892/ijo.2016.3694. Int J Oncol 42: 197-201, 2013</div>
					</div>
					<div>
						<div class="citationFormat">APA</div>
						<div class="citation">Yamamoto, H., Oshiro, R., Ohtsuka, M., Uemura, M., Haraguchi, N., Nishimura, J. ... Mori, M. (2013). Distinct expression of C4.4A in colorectal cancer detected by different antibodies Corrigendum in /10.3892/ijo.2016.3694. International Journal of Oncology, 42, 197-201. https://doi.org/10.3892/ijo.2012.1714</div>
					</div>
					<div>
						<div class="citationFormat">MLA</div>
						<div class="citation">Yamamoto, H.,  Oshiro, R.,  Ohtsuka, M.,  Uemura, M.,  Haraguchi, N.,  Nishimura, J.,  Takemasa, I.,  Mizushima, T.,  Doki, Y.,  Mori, M.&quot;Distinct expression of C4.4A in colorectal cancer detected by different antibodies Corrigendum in /10.3892/ijo.2016.3694&quot;. International Journal of Oncology 42.1 (2013): 197-201.</div>
					</div>
					<div>
						<div class="citationFormat">Chicago</div>
						<div class="citation">Yamamoto, H.,  Oshiro, R.,  Ohtsuka, M.,  Uemura, M.,  Haraguchi, N.,  Nishimura, J.,  Takemasa, I.,  Mizushima, T.,  Doki, Y.,  Mori, M.&quot;Distinct expression of C4.4A in colorectal cancer detected by different antibodies Corrigendum in /10.3892/ijo.2016.3694&quot;. International Journal of Oncology 42, no. 1 (2013): 197-201. https://doi.org/10.3892/ijo.2012.1714</div>
					</div>
				</div>
			</div>
		</div>

		<!-- Used to generate counter -->
		<input type="hidden" id="doid" value="10.3892/ijo.2012.1714" />
		<input type="hidden" id="toa"
			value="F" /> <input
			type="hidden" id="ptvstatus" value="F12" />
		<input type="hidden" id="user_id"
			value="" />
		<input type="hidden" id="journal_id" value="ijo" /> <input
			type="hidden" id="alert_track_citation_message"
			value="" />

		<script src="/resources/js/counter.js"></script>
		<script type='text/javascript'
			src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'></script>
		<script type="text/javascript">var addthis_config = addthis_config||{}; addthis_config.data_track_addressbar = false;</script>
		<script type="text/javascript"
			src="https://s7.addthis.com/js/300/addthis_widget.js#pubid=ra-4fe476482ba42f68"></script>

		<script async="async" crossorigin="anonymous"
			src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
		<script src="https://code.jquery.com/ui/1.11.1/jquery-ui.min.js"></script>
		<script src="https://cdn.tiny.cloud/1/560gz528beukra3kb9syq7iido8yu0in5iysfds42lt1q48q/tinymce/4.5.7-72/tinymce.min.js" type="text/javascript"></script> 


		<!-- Add fancyBox main JS and CSS files -->
		<script type="text/javascript"
			src="/resources/js/jquery.fancybox.js"></script>
		<script src="/resources/js/jquery.jgrowl.min.js"
			type="text/javascript"></script>

		<script>
    /*<![CDATA[*/
    	var articleId = 23489;
        $(document).ready(function () {
        	$(".rightsReservedCrossref").html((new Date()).getFullYear()-1);
        	        	
        	$("html, body").animate({"scrollTop":$("#titleId").offset().top}, 1000); 
        	
        	if(!Cookies.get('spandidos-gdpr')) {
        	 $('#navbar').show();
    		
        	$(window).scroll(function() {
          		 if($(window).scrollTop() + $(window).height() > $(document).height() - 50) {
          			 $('#navbar').hide();
          		   }
          		 if($(window).scrollTop() + $(window).height() <= $(document).height() - 50) {
          			 $('#navbar').show();
          		   }
          		});
    		 }
        	
            /* citation */
            
            $('#citation').on('click', '.citedBy', function (e) {
                e.preventDefault();
				if ($('#citations').html() != "") {
	                $("#citationDiv").show();				
				}
            });
            
            $('#citationAllArticlesId').on('click', '.citedBy', function (e) {
                e.preventDefault();
				if ($('#citations').html() != "") {
	                $("#citationDiv").show();				
				}
            });
            
            
            var urlTotalCount = $(".citedByCountId").attr('href');
            $.ajax({url: urlTotalCount, cache: false, success: function (result) {

	                if (result) {
	                	
	                	var count = result;
	                	
	                	if (count > 0) {
		                    $("#citationDiv").hide();
	    	                //$("#citations").html(result);
	        	        } else {
	        	        	$("#citedByIdViewArticles").text("No Articles");
	        	        }
	                	$("#citationCount").html(count);
	                	makeCitationsVisible();
	                } else {
	                	$("#citationCount").html(0);
	                	$("#citedByIdViewArticles").text("No Articles");
	                }
            	}

            });
            
            var url = $(".citedBy").attr('href');
            $.ajax({url: url, cache: false, success: function (result) {

                if (result) {
                	var items = $(result).children();
                	var count = items.length;
                	if (count > 0) {
	                    $("#citationDiv").hide();
    	                $("#citations").html(result);
    	                
    	                $("#citedByIdViewArticles").text("View Articles"); 
    	                
        	        }
                	
                	
                	//$("#citationCount").html(count);
                	makeCitationsVisible();
	                } else {
	                	//$("#citationCount").html(0);
	                	 $("#citedByIdViewArticles").text("No Articles"); 
	                }
            	}
            
            
            
            
            }); 
       
            
           var urlMoreLikeThis = $(".moreLikeThis").attr('href');
            $.ajax({url: urlMoreLikeThis, cache: false,success: function(result){
            	$("#moreLikeThisDiv .moreLikeThisClassFragment").html( $("#moreLikeThisUl", result) );   
		    }});

            /* Simple image gallery. Uses default settings */
            $('a.fancybox').fancybox({
                maxWidth: 1000,
                maxHeight: 800,
                helpers: {
                    title: {
                        type: 'inside'
                    }
                }
            });
        });
        
	var doi= $("#doid").val().split("/")[1];
	     	 $.ajax({
        	    type: "GET",
        	    url: "/retrieveArticleDownloadsAndViews/" +  doi, 
        	    dataType: "json",
        	    success: function(data, textStatus, jqXHR) {
        	   
       
        	    if (data!=null) {	    			
	    		  $("#postFullArticleViews").html(data.fullTextCount);
	    		  $("#postArticleDownloads").html(data.pdfCount);
	   			  $("#postPMCFullArticleViews").html(data.pmcFullTextCount);
	   			  $("#postArticlePMCDownloads").html(data.pmcPdfCount);
	   			  $("#postTotalFullArticleViews").html(data.totalFullTextCount);
	   			  $("#postTotalArticleDownloads").html(data.totalPdfCount);
	    	   	}
	    		else  {
	   			  $("#postFullArticleViews").html(0);
	   			  $("#postArticleDownloads").html(0);
	   			  $("#postPMCFullArticleViews").html(0);
	   			  $("#postArticlePMCDownloads").html(0);
	   			  $("#postTotalFullArticleViews").html(0);
	   			  $("#postTotalArticleDownloads").html(0);
	   	      }
		    },
        	   error: function (jqXHR, textStatus, errorThrown) {
		    }
		});
        
	     	 
	    function makeCitationsVisible(){
	    	try{
        		var searchAttribute = $(location).attr('search');
        		if (searchAttribute == '?citations' ) {
        			if ($('#citations').html() != "") {
	                	$("#citationDiv").show();				
					}
        		}
        	} catch (err) {
        		
        	}
	    }
	    
	    $('#toggleSM').click(function() {
	   		 $('.toggleSM').toggle();
		 });
	    
	   
	    $('#toggleSF').click(function() {
	   		 $('.toggleSF').toggle();
		 });
	    
	    
	    
	    $('#toggleMostCitedDimensions').click(function() {
	   		$('.toggleMostCitedDimensions').toggle();
		});
        
        $('#toggleMostCitedCrossRef').click(function() {
	   		$('.toggleMostCitedCrossRef').toggle();
		});
        
        $('#toggleRef').click(function() {
	   		 $('.toggleRef').toggle();
		 });
        
        $('#toggleFig').click(function() {
	   		 $('.toggleFig').toggle();
		 });
        
        var userId= $("#user_id").val();  
        if(userId!='') {
        $.ajax({
    		type: "GET",
   	   		 url: "/retrieveUserSelectedArticle/" + userId +"/" +  doi, 
   	    	dataType: "json",
   	    	success: function(data, textStatus, jqXHR) {
	  		 if (data) {
   				$('#track_citation').css("display", "none"); ;
   				$('#remove_track_citation').css("display", "block");
   	   		 }
   			else  {
   				$('#track_citation').css("display", "block") ;
   				$('#remove_track_citation').css("display", "none");
  	      	}
	   	 	},
   	   		error: function (jqXHR, textStatus, errorThrown) {
	   		 }    	
		});
        } else {
        	$('#track_citation').css("display", "block");
				$('#remove_track_citation').css("display", "none");
        }
        
        $(window).bind("load", function() {
        	var messsageTrackCitation= $('#alert_track_citation_message');	 
        	
        	if(messsageTrackCitation.length>0  && messsageTrackCitation.val()!=null && messsageTrackCitation.val()!='') {	         		
        		$.jGrowl( messsageTrackCitation.val());
        	 }
         });             
              
        /*]]>*/
    </script>


	</div>
	<!-- End Wrapper -->
</body>

</html>